Establishment and verification of a nomogram for predicting survival in patients with triple-positive breast cancer.

ABSTRACT:

Background

Triple-positive breast cancer (TPBC) is a specific type of breast cancer characterized by the positive expression of estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER-2). In recent years, the research on breast cancer has been increasing year by year, but there are few studies on TPBC, especially the lack of analysis with large sample size. In this study, sufficient samples were provided through the SEER database, explore the factors affecting the prognosis of TPBC, and construct a prediction model, in order to assess the individual survival of patients, and help clinicians accurately identify high-risk patients and develop personalized treatment plans.

Methods

Patients pathologically diagnosed with TPBC were recruited

SUBMITTER: Wang X 

PROVIDER: S-EPMC9469148 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature